SCHEMBL24590707

SCHEMBL24590707

COc1cccc(CCNC(=O)c2cccc(CN3CCOCC3)c2)c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C9 P11712 1/20 0.69
▸ CYP2C19 P33261 1/20 0.69
▸ KDM4E B2RXH2 1/20 0.66
▸ RAB9A P51151 2/20 0.58
▸ LMNA P02545 2/20 0.58
▸ SMN1; SMN2 Q16637 2/20 0.58
▸ NPC1 O15118 1/20 0.58
▸ TP53 P04637 1/20 0.58
▸ L3MBTL1 Q9Y468 1/20 0.58
▸ DRD4 P21917 3/20 0.56
▸ CHRM3 P20309 1/20 0.55
▸ KMT2A Q03164 2/20 0.54
▸ TSHR P16473 1/20 0.54
▸ CA1 P00915 1/20 0.53
▸ CA2 P00918 1/20 0.53
▸ CA7 P43166 1/20 0.53
▸ CA9 Q16790 1/20 0.53
▸ CA14 Q9ULX7 1/20 0.53
▸ KCNH2 Q12809 2/20 0.53
▸ ABL1 P00519 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23014313 0.86 CYP2C9 (0.66) CYP2C9CYP2C19KDM4ERAB9ALMNA
SCHEMBL15822962 0.82 CYP2C19 (1.00) CYP2C9CYP2C19KDM4ELMNANPC1
SCHEMBL30098940 0.82 CYP2C19 (1.00) CYP2C9CYP2C19KDM4ELMNANPC1
SCHEMBL13791587 0.81 SIGMAR1 (0.72) KDM4ERAB9ALMNASMN1; SMN2NPC1
SCHEMBL5681767 0.79 RAB9A (0.73) KDM4ERAB9ASMN1; SMN2NPC1KMT2A
SCHEMBL1013481 0.78 ALDH1A1 (0.62) KDM4ERAB9ALMNASMN1; SMN2NPC1
SCHEMBL10153821 0.78 ABL1 (0.59) CYP2C9RAB9ALMNASMN1; SMN2NPC1
SCHEMBL30512200 0.78 ALDH1A1 (0.62) KDM4ERAB9ALMNASMN1; SMN2NPC1
SCHEMBL4716344 0.77 CYP2C9 (0.69) CYP2C9CYP2C19KDM4ELMNATP53
Hydrochloric Acid SCHEMBL5012353 0.77 CACNA1G (0.84) CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4019495-A1 NOVEL COMPOUND HAVING CANCER METASTASIS INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION FOR INHIBITING CANCER METASTASIS AND INVASION OR TREATING COLORECTAL CANCER, COMPRISING COMPOUND Cellgentek Co., Ltd (KR) 2022-06-29 — — EP disclosed
Send feedback